Can‐Can Zheng

1.3k total citations · 2 hit papers
22 papers, 888 citations indexed

About

Can‐Can Zheng is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Can‐Can Zheng has authored 22 papers receiving a total of 888 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Can‐Can Zheng's work include RNA modifications and cancer (5 papers), Epigenetics and DNA Methylation (3 papers) and Peptidase Inhibition and Analysis (3 papers). Can‐Can Zheng is often cited by papers focused on RNA modifications and cancer (5 papers), Epigenetics and DNA Methylation (3 papers) and Peptidase Inhibition and Analysis (3 papers). Can‐Can Zheng collaborates with scholars based in China, Hong Kong and Australia. Can‐Can Zheng's co-authors include Bin Li, Wen Xu, Ming‐Liang He, Qing‐Yu He, Yaping Liu, Wen Xu, Long Liao, Yan He, Yang Wang and Xiaomei Yu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Oncogene.

In The Last Decade

Can‐Can Zheng

22 papers receiving 884 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment

2021 231 citations Yaping Liu, Can‐Can Zheng et al. SHILAP Revista de lepidopterología profile →
Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner

2023 98 citations Long Liao, Yan He et al. Cell Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Can‐Can Zheng China	15	618	269	217	90	62	22	888
Rareş Drulă Romania	11	601 1.0×	292 1.1×	189 0.9×	115 1.3×	43 0.7×	18	914
Shuang Lin China	15	442 0.7×	255 0.9×	163 0.8×	115 1.3×	69 1.1×	34	778
Zhilin Zou China	10	560 0.9×	222 0.8×	227 1.0×	133 1.5×	87 1.4×	24	901
Anuradha Kirtonia India	10	563 0.9×	284 1.1×	173 0.8×	106 1.2×	66 1.1×	12	904
Bo Lin China	16	521 0.8×	248 0.9×	183 0.8×	67 0.7×	100 1.6×	52	906
Sima Orouei Iran	16	571 0.9×	379 1.4×	167 0.8×	89 1.0×	75 1.2×	19	848
Haijun Zhang China	15	544 0.9×	229 0.9×	211 1.0×	154 1.7×	56 0.9×	24	870
Mihail Buse Romania	8	511 0.8×	176 0.7×	180 0.8×	99 1.1×	48 0.8×	14	878
Haolan Wang China	6	520 0.8×	192 0.7×	251 1.2×	124 1.4×	65 1.0×	9	861

Countries citing papers authored by Can‐Can Zheng

Since Specialization

Citations

This map shows the geographic impact of Can‐Can Zheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Can‐Can Zheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Can‐Can Zheng more than expected).

Fields of papers citing papers by Can‐Can Zheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Can‐Can Zheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Can‐Can Zheng. The network helps show where Can‐Can Zheng may publish in the future.

Co-authorship network of co-authors of Can‐Can Zheng

This figure shows the co-authorship network connecting the top 25 collaborators of Can‐Can Zheng. A scholar is included among the top collaborators of Can‐Can Zheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Can‐Can Zheng. Can‐Can Zheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shen, Peng, Xiaoying Zhuang, Yan He, et al.. (2025). Tumor Metastasis: Mechanistic Insights and Therapeutic Intervention. CityU Scholars. 4(1). 2 indexed citations

Pan, Hong, Jiaojiao Xu, Huifang Hu, et al.. (2024). CD24 promotes metastasis and chemoresistance by directly targeting Arf6-ERK pathway in esophageal squamous cell carcinoma. Cancer Letters. 594. 216994–216994. 6 indexed citations

Liao, Long, Yan He, Shujun Li, et al.. (2023). Lysine 2-hydroxyisobutyrylation of NAT10 promotes cancer metastasis in an ac4C-dependent manner. Cell Research. 33(5). 355–371. 98 indexed citations breakdown →

Yu, Xiaomei, Shujun Li, Ziting Yao, et al.. (2023). N4-acetylcytidine modification of lncRNA CTC-490G23.2 promotes cancer metastasis through interacting with PTBP1 to increase CD44 alternative splicing. Oncogene. 42(14). 1101–1116. 48 indexed citations

Xu, Wen, Long Liao, Wei Dai, et al.. (2023). Genome-wide CRISPR/Cas9 screening identifies a targetable MEST-PURA interaction in cancer metastasis. EBioMedicine. 92. 104587–104587. 14 indexed citations

Zheng, Can‐Can, Xiaomei Yu, Zhichao Liu, et al.. (2023). KCTD4 interacts with CLIC1 to disrupt calcium homeostasis and promote metastasis in esophageal cancer. Acta Pharmaceutica Sinica B. 13(10). 4217–4233. 3 indexed citations

He, Yan, Can‐Can Zheng, Jing Yang, et al.. (2023). Lysine butyrylation of HSP90 regulated by KAT8 and HDAC11 confers chemoresistance. Cell Discovery. 9(1). 74–74. 14 indexed citations

Liao, Long, Yan He, Jing Yang, et al.. (2022). Anti-HIV Drug Elvitegravir Suppresses Cancer Metastasis via Increased Proteasomal Degradation of m6A Methyltransferase METTL3. Cancer Research. 82(13). 2444–2457. 72 indexed citations

Zheng, Can‐Can, Long Liao, Yaping Liu, et al.. (2022). Blockade of Nuclear β‐Catenin Signaling via Direct Targeting of RanBP3 with NU2058 Induces Cell Senescence to Suppress Colorectal Tumorigenesis. Advanced Science. 9(34). e2202528–e2202528. 13 indexed citations

10.

Liu, Yaping, et al.. (2021). Molecular mechanisms of chemo‐ and radiotherapy resistance and the potential implications for cancer treatment. SHILAP Revista de lepidopterología. 2(3). 315–340. 231 indexed citations breakdown →

11.

Zheng, Can‐Can, Xiaomei Yu, Yiyao Liang, et al.. (2021). Targeting PFKL with penfluridol inhibits glycolysis and suppresses esophageal cancer tumorigenesis in an AMPK/FOXO3a/BIM-dependent manner. Acta Pharmaceutica Sinica B. 12(3). 1271–1287. 67 indexed citations

12.

Zheng, Can‐Can, et al.. (2021). Maprotiline Suppresses Cholesterol Biosynthesis and Hepatocellular Carcinoma Progression Through Direct Targeting of CRABP1. Frontiers in Pharmacology. 12. 689767–689767. 13 indexed citations

13.

Zheng, Can‐Can, Junqi Li, Qin‐Wen Liu, et al.. (2021). Lomerizine 2HCl inhibits cell proliferation and induces protective autophagy in colorectal cancer via the PI3K/Akt/mTOR signaling pathway. SHILAP Revista de lepidopterología. 2(3). 453–466. 22 indexed citations

14.

Xu, Wen, Zhi‐Hao Huang, Long Liao, et al.. (2020). Direct Targeting of CREB1 with Imperatorin Inhibits TGFβ2‐ERK Signaling to Suppress Esophageal Cancer Metastasis. Advanced Science. 7(16). 2000925–2000925. 42 indexed citations

15.

Li, Bin, Hong Pan, Can‐Can Zheng, et al.. (2019). Identification of miR-29c and its Target FBXO31 as a Key Regulatory Mechanism in Esophageal Cancer Chemoresistance: Functional Validation and Clinical Significance. Theranostics. 9(6). 1599–1613. 49 indexed citations

16.

Huang, Xiaohui, Yang Wang, Hong Pan, et al.. (2019). Benzethonium chloride suppresses lung cancer tumorigenesis through inducing p38-mediated cyclin D1 degradation.. PubMed. 9(11). 2397–2412. 18 indexed citations

17.

Wang, Yang, Xiaohui Huang, Can‐Can Zheng, et al.. (2018). Liensinine perchlorate inhibits colorectal cancer tumorigenesis by inducing mitochondrial dysfunction and apoptosis. Food & Function. 9(11). 5536–5546. 37 indexed citations

18.

Xu, Wen, Can‐Can Zheng, Yueming Wang, et al.. (2018). Synephrine Hydrochloride Suppresses Esophageal Cancer Tumor Growth and Metastatic Potential through Inhibition of Galectin-3-AKT/ERK Signaling. Journal of Agricultural and Food Chemistry. 66(35). 9248–9258. 28 indexed citations

19.

Hu, Huifang, Wen Xu, Yang Wang, et al.. (2017). Comparative Proteomics Analysis Identifies Cdc42-Cdc42BPA Signaling as Prognostic Biomarker and Therapeutic Target for Colon Cancer Invasion. Journal of Proteome Research. 17(1). 265–275. 16 indexed citations

20.

Wang, Yang, Jie Yang, Can‐Can Zheng, et al.. (2017). Propafenone suppresses esophageal cancer proliferation through inducing mitochondrial dysfunction.. PubMed. 7(11). 2245–2256. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact